PAVmed Inc. PAVM
As ofNov 20, 2026, 3:08 PM EST
- YTD
- -83.41%
- 1 year
- -89.70%
Held by funds
2 US ETFs and mutual funds hold PAVM · largest positions
Ownership
- Institutions 14.6%
- Insiders 10.4%
- Public and other holders 75.0%
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Manhattan Co. LLC | 5.42% | 600,000 | 387.00K | Sep 29, 2024 |
| Vanguard Group Inc | 2.54% | 281,015 | 181.25K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.75% | 82,496 | 53.21K | Sep 29, 2024 |
| Blackrock Inc. | 0.68% | 74,912 | 48.32K | Sep 29, 2024 |
| Obermeyer Wood Investment Counsel, Lllp | 0.19% | 21,500 | 13.87K | Sep 29, 2024 |
| State Street Corporation | 0.19% | 20,854 | 13.45K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.85% | 204,821 | 132.11K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.72% | 79,689 | 51.40K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.47% | 52,341 | 33.76K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.11% | 12,442 | 8.03K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 7,850 | 5.06K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 1,332 | 859 | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs PAVM, and what each was last paid
Lishan Aklog, Chairman & Chief Executive OfficerAverage age 54
| Name | Title | Pay | Age |
|---|---|---|---|
| Lishan Aklog | Chairman & Chief Executive Officer | $970K | 60 |
| Dennis McGrath | President & Chief Financial Officer | $602K | 69 |
| Michael Adam Gordon | Executive Vice President, General Counsel & Secretary | $574K | 51 |
| Brian J. deGuzman | Executive Vice President, Chief Technology & Compliance Officer | $428K | 61 |
| Shaun O'Neil | Executive Vice President & Chief Operating Officer | $417K | 44 |
| Suman Verma | Senior Vice President of Molecular Genetics & Chief Scientific Officer | — | — |
| Deepika A. Lakhani | Senior Vice President, Chief Regulatory & Quality Officer | — | — |
| Matthew Riley | Senior Director of Investor Relations | — | — |
| Victoria T. Lee | Executive Vice President & Chief Medical Officer | — | 40 |
| Joseph Virgilio | SVP & Chief Business Officer of Medical Devices | — | 51 |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAXTER TIMOTHY E | Director | Stock Award(Grant) | Feb 21, 2024 | 65,000 |
| COX JAMES L | Director | Stock Award(Grant) | Feb 21, 2024 | 65,000 |
| GLENNON MICHAEL J | Director | Stock Award(Grant) | Feb 21, 2024 | 315,000 |
| HARVEY JOAN B. | Director | Stock Award(Grant) | Feb 21, 2024 | 65,000 |
| WHITE DEBRA JAYNE | Director | Stock Award(Grant) | Feb 21, 2024 | 65,000 |
